DocuSign, Inc. (DocuSign®) launched its DocuSign Winter ’15 Release, which includes an improved signing experience based on customer feedback from focus groups, usability studies, user testing and more. DocuSign’s new signing experience features both visual and interaction design enhancements that reflect the company’s commitment to customer-centric product innovation, www.docusign.com/docusign-winter-15-release.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7312253-docusign-winter-15/
GAC Motor’s display of its globalization drive and the latest models at the North American International Auto Show ticked all the right boxes as the leading automotive manufacturer in China built up intimacy with international customers, dealers and business partners.
GAC put its best foot forward in reinforcing its ambitions of making cars for the world as it shed the light on its go–outbound campaign during the international auto exhibition in Detroit that concluded on January 25, 2015.
“After meticulous planning and careful studies, we start to create our own brands by adopting international standards,” said Wu Song, general manager of GAC Motor. “We are confident that GAC Motor can churn out world-class vehicles to compete in the international market.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7447151-gac-motors-detroit-auto-show/
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
A recently published scientific study from Lund University by lead researcher Charlotte Erlanson-Albertsson, MD, PhD found that subjects who were trying to lose weight and used the patented spinach extract Appethyl on a daily basis lost 43 percent more weight compared to those ingesting a placebo.
In this clinical trial, overweight women were given either a daily five gram dose of Appethyl or a control drink immediately before breakfast. Researchers found that the weight of the women ingesting Appethyl decreased significantly at 43 percent more than subjects ingesting the control drink.
This is one of three studies that also compared the effects of Appethyl after 90 days with those found after the first dose and found no decline of effects, indicating that Appethyl takes effect after the first dose and is just as effective after long-term use. One study showed that Appethyl reduced hunger by 25 percent four hours after consumption, in addition to reducing thoughts about food by 33 percent.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7426951-appethyl-spinach-extract/
It won’t cure the common cold, but Appvion, Inc.’s new eco-friendly receipt paper, Alpha Free, proves vitamin C works wonders at the cash register.
Alpha Free is the first and only thermal receipt paper to use a vitamin C formulation in place of phenols like BPA or BPS. Whole Foods Market is now the first major national grocery retailer in America to use the new, natural and sustainable choice in receipt paper that shoppers can feel good about at checkout.
”In the last few years, multiple studies concluded that BPA found in receipts can be absorbed into the skin. If you are someone who handles receipts daily, like a cashier, that can be scary,“ said Dave Pauly, Alpha Free Product Manager for Appvion. ”A growing number of shoppers and employees are looking for more natural product options. That movement encouraged us to develop our vitamin C-based receipt paper, Alpha Free.“
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7541551-appvion-alpha-free-receipts/
Only 3 vehicles of more than 100 evaluated by the Insurance Institute for Highway Safety have child restraint installation hardware that earns a good rating for ease of use, while more than half have hardware that is poor or marginal.
The Institute's new LATCH ratings will serve as a resource for families looking for a vehicle that makes it easy to transport their children safely. They also are intended to encourage vehicle manufacturers to pay attention to this equipment and make improvements. Properly installed, age-appropriate child restraints provide considerably more protection for children in crashes than safety belts alone. However, observational studies have found that parents and caregivers often fail to secure them tightly or make other installation mistakes.
LATCH, which stands for Lower Anchors and Tethers for Children, is intended to make it easier to install a child seat properly. It works: Child restraints installed with LATCH, rather than with vehicle safety belts, are more likely to be installed correctly, research has shown. But in many vehicles, LATCH hardware could be better. Parents are more likely to install the seat correctly when the LATCH hardware meets certain key ease-of-use criteria.
The First Graduation Ceremony of Nazarbayev University (NU) took place on June 15, 2015. The President of Kazakhstan, Nursultan Nazarbayev addressed the Class of 2015.
Nazarbayev University, created on the initiative of the President of Kazakhstan in 2010, is fast becoming a leading research university in Kazakhstan and the region. The first cohort of graduating students consists of 446 undergraduate and graduate students. Of the 365 bachelor degree holders, 115 have been accepted to Masters and PhD programs in leading universities of the world, some 90 graduates plan to continue their studies at Nazarbayev University; more than 80 received job offers from leading national and international companies, and another 50 are interviewing with prospective employers.
To view the Multimedia News Release, go to http://www.multivu.com/players/uk/7560951-nazarbayev-university-graduation-ceremony/
Subaru of America, Inc. and Center for Pet Safety (CPS), a registered 501(c)(3) non-profit research and consumer advocacy organization, announced today the results of the 2015 Crate and Carrier Crashworthiness Studies - a collaborative initiative to examine the effectiveness and safety of pet crates and carriers in the event of a crash. After several eye-opening and informative tests - including instances of complete failure - three top products emerged; CPS has selected the Gunner Kennels G1 Intermediate with 8’ Tie Down Straps as the 2015 Top Performing Crate and both the PetEgo Forma Frame Jet Set Carrier with ISOFIX-Latch Connection and Sleepypod Mobile Pet Bed with PPRS Handilock as the 2015 Top Performing Carriers.
To view the multimedia news release, go to http://www.multivu.com/players/English/7074157-subaru-pet-safety/
Today, GENYOUth announced the launch of Fuel Up to Play 60 en español, an evolution of its national flagship program. The program encourages Spanish-speaking communities nationwide to live healthier lifestyles through good nutrition and physical activity. Fuel Up to Play 60 launched a redesigned website (FuelUpToPlay60.com) that provides Spanish-language content and materials, extending the reach and access of the program to students, teachers and families across the country. Several organizations have supported the effort, including the PepsiCo Foundation, which has provided a previously announced grant of $550,000 to develop Spanish-language materials and resources. In addition the PepsiCo Foundation will provide another $100,000 for mini-grants for health and wellness activities and programming within Los Angeles Unified School District and Miami-Dade County Public Schools.
Fuel Up to Play 60, a program founded by the National Football League (NFL) and National Dairy Council (NDC), is designed to engage and empower youth to take action for their own health by implementing long-term, positive nutrition and physical activity changes for themselves, their schools and their communities. Studies show that physical fitness may benefit brain health and academic performance, suggesting active kids may do better. However, only 1 in 3 kids are active every day, potentially leaving many at a disadvantage inside and outside of the classroom.
To view the multimedia release go to:
http://www.multivu.com/players/English/7646551-fuel-up-to-play-60/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
